A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotyping

Thomas W. Gardner, Jeffrey Sundstrom

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This paper presents a new approach to the prevention and treatment of early stage diabetic retinopathy before vision is severely impaired. This approach includes two major steps. The first step is to understand the mechanisms of vision impairment and classify diabetic retinopathy on the basis of pathophysiologic adaptations, rather than on the presence of advanced pathologic lesions, as defined by current clinical practice conventions. The second step is to develop patient-specific molecular diagnoses of diabetic retinopathy so that patients can be treated based on their individual characteristics, a process analogous to the individualized diagnosis and treatment of cancer patients. This step is illustrated by proteomic analysis of vitreous fluid that reveals evidence of neuroretinal degeneration and inflammation, as well as vascular proliferation. Together, these steps may lead to improved means to preserve vision in the ever-increasing number of patients with diabetes worldwide.

Original languageEnglish (US)
Pages (from-to)153-160
Number of pages8
JournalVision Research
Volume139
DOIs
StatePublished - Oct 1 2017

Fingerprint

Diabetic Retinopathy
Therapeutics
Proteomics
Blood Vessels
Inflammation
Neoplasms

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Sensory Systems

Cite this

@article{0c87cdc11d144ac8b3f04a9ce9b43455,
title = "A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotyping",
abstract = "This paper presents a new approach to the prevention and treatment of early stage diabetic retinopathy before vision is severely impaired. This approach includes two major steps. The first step is to understand the mechanisms of vision impairment and classify diabetic retinopathy on the basis of pathophysiologic adaptations, rather than on the presence of advanced pathologic lesions, as defined by current clinical practice conventions. The second step is to develop patient-specific molecular diagnoses of diabetic retinopathy so that patients can be treated based on their individual characteristics, a process analogous to the individualized diagnosis and treatment of cancer patients. This step is illustrated by proteomic analysis of vitreous fluid that reveals evidence of neuroretinal degeneration and inflammation, as well as vascular proliferation. Together, these steps may lead to improved means to preserve vision in the ever-increasing number of patients with diabetes worldwide.",
author = "Gardner, {Thomas W.} and Jeffrey Sundstrom",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.visres.2017.03.006",
language = "English (US)",
volume = "139",
pages = "153--160",
journal = "Vision Research",
issn = "0042-6989",
publisher = "Elsevier Limited",

}

A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotyping. / Gardner, Thomas W.; Sundstrom, Jeffrey.

In: Vision Research, Vol. 139, 01.10.2017, p. 153-160.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotyping

AU - Gardner, Thomas W.

AU - Sundstrom, Jeffrey

PY - 2017/10/1

Y1 - 2017/10/1

N2 - This paper presents a new approach to the prevention and treatment of early stage diabetic retinopathy before vision is severely impaired. This approach includes two major steps. The first step is to understand the mechanisms of vision impairment and classify diabetic retinopathy on the basis of pathophysiologic adaptations, rather than on the presence of advanced pathologic lesions, as defined by current clinical practice conventions. The second step is to develop patient-specific molecular diagnoses of diabetic retinopathy so that patients can be treated based on their individual characteristics, a process analogous to the individualized diagnosis and treatment of cancer patients. This step is illustrated by proteomic analysis of vitreous fluid that reveals evidence of neuroretinal degeneration and inflammation, as well as vascular proliferation. Together, these steps may lead to improved means to preserve vision in the ever-increasing number of patients with diabetes worldwide.

AB - This paper presents a new approach to the prevention and treatment of early stage diabetic retinopathy before vision is severely impaired. This approach includes two major steps. The first step is to understand the mechanisms of vision impairment and classify diabetic retinopathy on the basis of pathophysiologic adaptations, rather than on the presence of advanced pathologic lesions, as defined by current clinical practice conventions. The second step is to develop patient-specific molecular diagnoses of diabetic retinopathy so that patients can be treated based on their individual characteristics, a process analogous to the individualized diagnosis and treatment of cancer patients. This step is illustrated by proteomic analysis of vitreous fluid that reveals evidence of neuroretinal degeneration and inflammation, as well as vascular proliferation. Together, these steps may lead to improved means to preserve vision in the ever-increasing number of patients with diabetes worldwide.

UR - http://www.scopus.com/inward/record.url?scp=85026660849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026660849&partnerID=8YFLogxK

U2 - 10.1016/j.visres.2017.03.006

DO - 10.1016/j.visres.2017.03.006

M3 - Article

C2 - 28438679

AN - SCOPUS:85026660849

VL - 139

SP - 153

EP - 160

JO - Vision Research

JF - Vision Research

SN - 0042-6989

ER -